Federal Data HubHRSA 340B · JSON

LIVINGSTONE COMMUNITY DEVELOPMENT CORPORATION

Livingstone Community Health Clinic · 340B ID FQHCLA353

ParticipatingFQHCLA

LIVINGSTONE COMMUNITY DEVELOPMENT CORPORATION is a FQHCLA enrolled in the federal 340B Drug Pricing Program in Stanton, CA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 27 contract-pharmacy arrangement(s) (19 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (27)

PharmacyLocationBeginTerminatedPharmacy ID
CYSTIC FIBROSIS SERVICES, LLCFRISCO, TX2018-04-01110069
PRIME THERAPEUTICS SPECIALTY PHARMACY LLORLANDO, FL2018-04-012022-10-0139182
WALGREEN COFOUNTAIN VALLEY, CA2022-01-019558
WALGREEN CO.ANAHEIM, CA2018-10-019566
WALGREEN CO.ANAHEIM, CA2018-10-019562
WALGREEN CO.ANAHEIM, CA2018-10-012020-03-209561
WALGREEN CO.ANAHEIM, CA2022-01-019564
WALGREEN CO.ANAHEIM, CA2018-10-019565
WALGREEN CO.BUENA PARK, CA2018-10-019512
WALGREEN CO.CYPRESS, CA2018-10-019514
WALGREEN CO.FULLERTON, CA2018-10-019568
WALGREEN CO.GARDEN GROVE, CA2018-10-012019-11-119569
WALGREEN CO.GARDEN GROVE, CA2018-10-019570
WALGREEN CO.HUNTINGTON BEACH, CA2018-10-019542
WALGREEN CO.HUNTINGTON BEACH, CA2018-10-019543
WALGREEN CO.LA HABRA, CA2018-10-012023-10-059516
WALGREEN CO.LA PUENTE, CA2022-01-015182
WALGREEN CO.LONG BEACH, CA2022-01-012022-01-03118230
WALGREEN CO.MISSION VIEJO, CA2022-01-01123102
WALGREEN CO.STANTON, CA2018-04-012025-03-269518
WALGREEN CO.TUSTIN, CA2022-01-019560
WALGREEN CO.WEST COVINA, CA2022-01-0179440
WALGREEN CO.WESTMINSTER, CA2018-10-012019-11-149551
WALGREENS SPECIALTY PHARMACY, LLCCANTON, MI2018-04-014981
WALGREENS SPECIALTY PHARMACY, LLCBEAVERTON, OR2018-04-012021-10-014982
WALGREENS SPECIALTY PHARMACY, LLCPITTSBURGH, PA2018-04-014953
WALGREENS SPECIALTY PHARMACY, LLCFRISCO, TX2018-04-014980

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.